BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 17454262)

  • 1. Does the developmental status of Valpha14i NKT cells play a role in disease?
    Matsuda JL; Gapin L
    Int Rev Immunol; 2007; 26(1-2):5-29. PubMed ID: 17454262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
    Ikarashi Y; Iizuka A; Heike Y; Yoshida M; Takaue Y; Wakasugi H
    Immunol Lett; 2005 Nov; 101(2):160-7. PubMed ID: 16054231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward an understanding of NKT cell biology: progress and paradoxes.
    Kronenberg M
    Annu Rev Immunol; 2005; 23():877-900. PubMed ID: 15771592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective requirement for c-Myc at an early stage of V(alpha)14i NKT cell development.
    Mycko MP; Ferrero I; Wilson A; Jiang W; Bianchi T; Trumpp A; MacDonald HR
    J Immunol; 2009 Apr; 182(8):4641-8. PubMed ID: 19342639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
    Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invariant and noninvariant natural killer T cells exert opposite regulatory functions on the immune response during murine schistosomiasis.
    Mallevaey T; Fontaine J; Breuilh L; Paget C; Castro-Keller A; Vendeville C; Capron M; Leite-de-Moraes M; Trottein F; Faveeuw C
    Infect Immun; 2007 May; 75(5):2171-80. PubMed ID: 17353286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type.
    Stenström M; Sköld M; Ericsson A; Beaudoin L; Sidobre S; Kronenberg M; Lehuen A; Cardell S
    Eur J Immunol; 2004 Jan; 34(1):56-65. PubMed ID: 14971030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate antigen-specific effector functions by TCR-transgenic CD8+ NKT cells.
    Wingender G; Berg M; Jüngerkes F; Diehl L; Sullivan BA; Kronenberg M; Limmer A; Knolle PA
    Eur J Immunol; 2006 Mar; 36(3):570-82. PubMed ID: 16506291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets.
    Johnston B; Kim CH; Soler D; Emoto M; Butcher EC
    J Immunol; 2003 Sep; 171(6):2960-9. PubMed ID: 12960320
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Developmental program of mouse Valpha14i NKT cells.
    Matsuda JL; Gapin L
    Curr Opin Immunol; 2005 Apr; 17(2):122-30. PubMed ID: 15766670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoregulation of autoimmunity by natural killer T cells.
    Linsen L; Somers V; Stinissen P
    Hum Immunol; 2005 Dec; 66(12):1193-202. PubMed ID: 16690406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular profiling reveals distinct functional attributes of CD1d-restricted natural killer (NK) T cell subsets.
    Rolf J; Berntman E; Stenström M; Smith EM; Månsson R; Stenstad H; Yamagata T; Agace W; Sigvardsson M; Cardell SL
    Mol Immunol; 2008 May; 45(9):2607-20. PubMed ID: 18304639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recognition and function of Valpha14 NKT cells.
    Taniguchi M; Nakayama T
    Semin Immunol; 2000 Dec; 12(6):543-50. PubMed ID: 11145860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Graft-versus-host disease in recipients of grafts from natural killer T cell-deficient (Jalpha281(-/-)) donors.
    Ellison CA; Taniguchi M; Fischer JM; Hayglass KT; Gartner JG
    Immunology; 2006 Nov; 119(3):338-47. PubMed ID: 16879624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invariant NKT and NKT-like lymphocytes: two different T cell subsets that are differentially affected by ageing.
    Peralbo E; Alonso C; Solana R
    Exp Gerontol; 2007 Aug; 42(8):703-8. PubMed ID: 17604928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased infiltration of CD1d and natural killer T cells in periodontal disease tissues.
    Amanuma R; Nakajima T; Yoshie H; Yamazaki K
    J Periodontal Res; 2006 Feb; 41(1):73-9. PubMed ID: 16409258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
    Kuwatani M; Ikarashi Y; Iizuka A; Kawakami C; Quinn G; Heike Y; Yoshida M; Asaka M; Takaue Y; Wakasugi H
    Immunol Lett; 2006 Jul; 106(1):82-90. PubMed ID: 16806496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Porcine T lymphocytes and NK cells--an update.
    Gerner W; Käser T; Saalmüller A
    Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors.
    Egawa T; Eberl G; Taniuchi I; Benlagha K; Geissmann F; Hennighausen L; Bendelac A; Littman DR
    Immunity; 2005 Jun; 22(6):705-16. PubMed ID: 15963785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK and NKT cell functions in immunosenescence.
    Mocchegiani E; Malavolta M
    Aging Cell; 2004 Aug; 3(4):177-84. PubMed ID: 15268751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.